Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Xarelto for Prevention of Stroke in Patients With Atrial Fibrillation (XANTUS)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Bayer
ClinicalTrials.gov Identifier:
NCT01606995
First received: May 24, 2012
Last updated: July 22, 2016
Last verified: May 2016